Consequently, this work was designed to study the potential protective effects of GAL in the management of testicular impairment secondary to RA through targeting Caspase-3, NF-κB p65, and IL-6/JAK/STAT3/SOCS3 signaling. This evidence concerns the gene CASP3 and rheumatoid arthritis.